10 Minute Protocol for UK Clinicians Managing Filler Complications

Stop injecting the moment a complication is suspected, check capillary refill and skin colour for signs of vascular compromise, and treat time-critical events with hyaluronidase immediately, following ACE Group guidance. Document everything with photographs, escalate early if there is any doubt, and keep the patient informed and reassured throughout. Speed and calm decision-making matter more than perfection in the first ten minutes.

TL;DR:

• Rapid recognition of vascular occlusion relies on capillary refill over two seconds, sudden blanching, livedo patterns, and disproportionate pain, requiring immediate hyaluronidase treatment.
• Emergency protocols include stopping injection, photo documentation, conservative maneuvers, high-dose hyaluronidase infiltration, and swift escalation if no rapid improvement or neurological signs develop.
• Most complications such as bruising, swelling, or mild erythema resolve within days to weeks with conservative management, but worsening pain or swelling after 72 hours signals urgent review.
• Prevention depends on thorough anatomical knowledge, cautious injection techniques, and structured emergency preparedness like team drills and in-stock supplies, not equipment or tools alone.
• Clear patient communication, proactive follow-up, and professional documentation are essential to managing psychological impacts, legal obligations, and reducing liability in case of adverse events.

Table of Contents

• Common complications: bruising, swelling, erythema and how to triage them
• How do you recognise a vascular occlusion early?
• What is the immediate clinic protocol for suspected vascular occlusion?
• Escalation, referral pathways and your professional obligations
• Prevention and clinic systems that actually reduce risk
• Managing nodules, infection and delayed inflammatory reactions
• What NexGen Clinics clinicians have learned about managing complications
• Psychological impact and patient communication strategies when managing complications
• Legal and regulatory considerations for UK aesthetic practitioners
• Insurance and indemnity: what you need before a complication happens
• How long should you monitor a patient after a filler complication?
• A practitioner's checklist for when things go wrong
• How some clinics support clinicians managing filler complications
• Sources
• FAQ

Common complications: bruising, swelling, erythema and how to triage them

Most reactions to dermal filler are benign and self-limiting. Bruising typically resolves within 7 to 14 days, and swelling peaks at 24 to 48 hours before settling over the following few days. Tenderness and mild erythema at injection points are expected and rarely warrant intervention beyond reassurance.

Conservative management covers the vast majority of cases you'll see in clinic:

• Cold compresses for the first 24 to 48 hours to limit swelling and bruising
• Simple analgesia (paracetamol) rather than NSAIDs, which increase bleeding risk
• Antihistamines for itching or mild allergic-type reactions
• Elevation and avoidance of heat, alcohol and strenuous exercise for 48 hours
• Arnica or bromelain supplements if the patient wishes, though evidence is mixed

The judgement call is knowing which "normal" reaction is quietly turning into something else. Rapidly worsening pain out of proportion to the procedure, swelling that continues to progress past 72 hours rather than plateauing, or erythema that spreads rather than fades are all red flags. Any of these findings justifies a same-day review rather than a "call us if it gets worse" instruction. Pain that escalates rather than eases with time is the single most reliable early indicator that something beyond a normal inflammatory response is happening, and it should never be dismissed as anxiety or low pain tolerance.

How do you recognise a vascular occlusion early?

Capillary refill time (CRT) is the fastest bedside test you have. Press firmly on the skin for two seconds, release, and count how long colour takes to return. Under two seconds is normal; anything beyond that, especially alongside pain or blanching, points towards vascular compromise and needs immediate action.

Look for these signals during and immediately after injection:

• Blanching: a sudden white or mottled patch, often the first visible sign of arterial compromise
• Livedo pattern: a lace-like, dusky discolouration suggesting impaired venous or arterial flow
• Disproportionate pain: patients often describe it as far worse than the injection itself
• Delayed capillary refill: CRT over two seconds in the affected area
• Visual disturbance: blurring, partial vision loss, or eye pain, which signals a potential ocular embolism

Statistic Callout: Retinal ischaemia can cause irreversible damage within a very narrow window. Some evidence suggests neuronal injury may begin within 12 to 15 minutes of vascular occlusion, with retinal circulation loss potentially becoming permanent within 60 to 90 minutes. There is no time to "wait and see" with ocular symptoms.

Any visual change following filler, however subtle the patient's description, is an emergency until proven otherwise.

What is the immediate clinic protocol for suspected vascular occlusion?

When vascular compromise is suspected, the team needs a rehearsed sequence rather than improvisation under pressure. This is the moment a laminated role card earns its place in your emergency pack.

1. Stop and stabilise. Cease injecting immediately, reassure the patient calmly, photograph the affected area, and measure CRT. Assign roles on the spot: one clinician manages the patient, one records timings and observations, one contacts help if needed.
2. Try conservative manoeuvres first. Firm massage over the area, gentle tapping, and a warm compress can sometimes restore flow within minutes. Reassess CRT and colour after each attempt before moving on.
3. Administer hyaluronidase without delay. The ACE Group's high-dose pulsed protocol recommends large-volume infiltration across the affected territory, often in the range of 450 to 1,500 units depending on the area and severity, repeated hourly until skin colour and capillary refill improve. Treatment within four hours gives the best outcomes, and intervention up to 48 hours can still help.
4. Add adjuncts where appropriate, and know the cautions. Aspirin 300mg stat, then 75mg daily where there's no contraindication, helps limit platelet aggregation during reperfusion. Nitroglycerin paste has historically been suggested to promote vasodilation, but current evidence for its benefit is weak, and it should be used with caution rather than routinely. Steroids and sildenafil are not recommended as first-line measures for vascular occlusion and shouldn't substitute for hyaluronidase and escalation.
5. Escalate without hesitation. If there's no rapid improvement, or if ocular or neurological signs appear at any point, call an ambulance and alert ophthalmology directly. Consider accompanying the patient to hospital, and prepare a clear handover along with contact details for your medical defence organisation.

Pro Tip: Keep pre-measured hyaluronidase vials labelled with their unit strength in your emergency pack, alongside a printed role card. Fumbling with reconstitution calculations during an occlusion wastes minutes you don't have.

Escalation, referral pathways and your professional obligations

A fast, well-prepared referral can be the difference between full recovery and lasting damage. Emergency departments and ophthalmology teams need specific information fast, not a general account of "a filler reaction."

Your handover should include:

• Time of onset and time treatment began
• Exact hyaluronidase units administered and timing of each dose
• Photographs taken at each stage
• Product used (brand, lot number where available) and injection site
• Direct contact details for the treating clinician

Preparing a one-page written summary to send with the patient speeds up triage considerably. Beyond the clinical response, UK practice standards set clear professional expectations. The Journal of Aesthetic Nursing practice standard requires practitioners to have pre-agreed fast-track referral pathways in place before a complication happens, not scrambled together afterwards, and to keep contemporaneous documentation throughout. Duty of candour means being honest with the patient about what happened and what you're doing about it, without delay or evasion.

Significant adverse events should be reported through the MHRA Yellow Card scheme, which feeds into national surveillance on product and treatment safety. Inform your medical defence organisation and insurer as soon as a serious complication occurs, not after the outcome is known, and maintain an incident log that feeds into regular clinical audit.

Prevention and clinic systems that actually reduce risk

Most serious complications are prevented long before the needle touches skin. Sound anatomical knowledge, cautious technique and a well-drilled team do more for patient safety than any single piece of equipment.

1. Work strictly within your competence. If a presentation, anatomical area or complexity sits outside your training, escalate to a more experienced colleague rather than pressing ahead. Professional guidance is explicit that scope-of-practice limits exist precisely because complications punish overreach.
2. Reduce risk at the point of injection. Identify scar tissue and previous filler sites during assessment, favour small boluses and slow injection speed, and hold a working knowledge of facial vascular anatomy for every zone you treat.
3. Keep a complete emergency stock list. Hyaluronidase (with clear unit labelling), aspirin, adrenaline, nitroglycerin paste, and basic resuscitation equipment should be checked and in date at every clinic session, not located "somewhere in the stock room."
4. Build the operational scaffolding around treatment. Structured consent conversations, baseline photographs before every procedure, a visible emergency contact number, and an out-of-hours escalation policy all reduce the gap between problem and response.
5. Rehearse, don't just document. Running periodic team drills for vascular occlusion, much like a fire drill, means the response becomes automatic under pressure rather than improvised.

Pro Tip: A conservative volume per session, reviewed and topped up at a follow-up visit rather than delivered all at once, is one of the simplest ways to reduce both occlusion risk and over-correction complaints.

Managing nodules, infection and delayed inflammatory reactions

Delayed complications present differently to acute vascular events and are easy to misread. A nodule appearing weeks or months after treatment could be a straightforward inflammatory reaction, a biofilm-related infection, or filler migration, and getting the diagnosis wrong changes your entire treatment plan.

Key considerations for delayed presentations:

• Delayed inflammatory reactions often follow a viral illness, vaccination or dental work, presenting as sudden swelling around old filler sites months or years after treatment.
• Suspected infection should be treated with antibiotics before you consider dissolving the product; starting hyaluronidase first risks spreading infective material through tissue. ACE Group guidance suggests a course of roughly one week of antibiotics ahead of dissolving an inflammatory or infective nodule.
• Hyaluronidase for over-correction or migration works well once infection is ruled out, but always observe the patient for around 60 minutes afterwards, since allergic reactions including anaphylaxis are a recognised, if uncommon, risk.
• Collaborate with microbiology or a specialist colleague where infection doesn't respond to first-line antibiotics or where diagnosis remains unclear.

What NexGen Clinics clinicians have learned about managing complications

Conservative dosing isn't caution for its own sake, it's a clinical decision rule. If a patient presents with mild asymmetry or firmness within days of treatment, the default should lean towards observation and review rather than immediate dissolving, unless vascular signs are present.

• Emergency role matrix: the treating clinician manages the patient and administers hyaluronidase; an assistant prepares equipment and photographs; a note-taker logs every timing and dose; a designated caller contacts ambulance services or ophthalmology, freeing the clinical team to focus entirely on the patient.
• Follow-up cadence: patients treated for a vascular event are typically reviewed at 24 hours, 72 hours, and again at two weeks, with clear documentation of resolution at each point.

Clear role allocation in the first ten minutes of a suspected occlusion prevents the confusion that turns a manageable complication into a serious one. Every second spent working out who does what is a second not spent treating the patient.

Psychological impact and patient communication strategies when managing complications

A filler complication is frightening for patients, often disproportionately to the medical severity. Visible bruising, asymmetry or swelling can trigger real distress, particularly when it affects the face and the patient has to appear in public or at work within days.

Acknowledge the emotional weight of what's happening before moving straight into clinical explanation. Patients remember how they were treated during a crisis far more vividly than the treatment itself. Explain what's happening in plain language, what you're doing about it, and what the realistic timeline for resolution looks like, and avoid minimising language such as "it's nothing to worry about" when the patient can see for themselves that something has changed.

Regular, proactive contact matters more than patients often admit. A short check-in call at 24 hours, even when everything looks stable, reduces anxiety and builds trust that you're actively managing their care rather than having sent them away to cope alone. Where a complication has taken longer to resolve, or where scarring or pigment change is a realistic possibility, be honest early rather than waiting for the patient to ask. Patients who feel informed and included in decisions are markedly less likely to escalate a complaint into a formal claim, regardless of the clinical outcome. Clear communication also supports your duty of candour obligations, which require open, timely disclosure of what happened and what's being done about it.

Legal and regulatory considerations for UK aesthetic practitioners

Dermal filler remains a largely unregulated product in the UK in terms of who can inject it, but the standard of care expected from whoever does inject it is not optional. Practitioners are held to a professional and, where applicable, statutory standard regardless of their background, whether that's a doctor, dentist, nurse prescriber or non-medical injector.

The JCCP and CPSA code of practice sets out expectations around qualifications, insurance, consent and complication management that practitioners are expected to meet whether or not they sit on a statutory register. Working outside your training, failing to obtain informed consent, or failing to have a functioning referral pathway for complications all increase liability exposure significantly if something goes wrong.

Liability in these cases usually turns on whether the standard of care matched what a reasonably competent practitioner in the same field would have done, not simply on whether a complication occurred. Complications happen even with excellent technique; poor recognition, delayed treatment or absent documentation are what typically drive successful claims. Practitioners working from rented chairs or mobile setups without a fixed clinic base face particular scrutiny over whether adequate emergency provision and referral arrangements genuinely existed at the point of treatment.

Insurance and indemnity: what you need before a complication happens

Professional indemnity cover for aesthetic practice needs to explicitly cover the treatments you perform, not just a generic clinical indemnity policy. Injectable treatments, particularly higher-risk areas like the nose and glabella, are sometimes excluded or capped differently depending on the policy and provider, so checking your certificate against your actual treatment list matters more than assuming you're covered.

Notify your insurer or medical defence organisation as soon as a significant complication occurs, rather than waiting to see whether the patient complains. Most policies require early notification as a condition of cover, and a delayed report can complicate a claim even when your clinical management was sound. Keep your incident log, photographs and hyaluronidase batch records together as a single file for each event, since insurers and defence organisations will request exactly this evidence if a claim is made later.

Clinics offering training or supervision to less experienced injectors should also check that indemnity extends to that teaching relationship, since supervisory liability is a distinct exposure from direct treatment liability.

How long should you monitor a patient after a filler complication?

Resolution timelines vary by complication type, and setting clear monitoring milestones protects both patient and practitioner. For a treated vascular event, review at 24 hours, 72 hours, and two weeks gives a structured picture of recovery, with photography at each stage to compare against baseline.

For nodules or delayed inflammatory reactions treated with antibiotics or hyaluronidase, a follow-up at one week and again at four weeks is reasonable to confirm resolution or identify the need for further intervention. Persistent firmness, discolouration or pain beyond the expected window at any of these checkpoints is the trigger to escalate rather than continue observing. Full resolution should mean normal skin colour, normal sensation, and no residual pain or firmness, not merely "looks better than it did."

A practitioner's checklist for when things go wrong

Every complication comes down to the same sequence: stop, assess, treat, document, escalate. Hold that order in your head and you'll rarely go wrong on the fundamentals, whatever the specific presentation turns out to be.

Seeking help early is not a failure. The practitioners who get into genuine difficulty are usually the ones who waited too long, hoping it would resolve on its own. Use your local networks, your medical defence organisation, and colleagues with more experience the moment you're unsure.

— Ms Sandra Petraskaite

How some clinics support clinicians managing filler complications

Practitioners rarely feel underprepared because they lack knowledge. They feel underprepared because their team has never rehearsed the sequence under pressure. Some clinics offer clinician-led training built around exactly this gap: structured emergency response rehearsals, conservative dosing frameworks, and practical protocols developed from real clinic workflows rather than theory alone.

Where many training providers stop at technique, some clinics build the operational layer around it, role allocation, documentation habits and escalation drills, so a team's response to a vascular event is automatic rather than improvised. The clinic's own conservative approach to volume and dosing, detailed in its guide to how much filler you actually need, reflects the same risk-reduction thinking that runs through this article. Clinics wanting a structured route into this can review NexGen's treatment and training pathways or explore the signature packages designed for practitioners seeking a more curated programme. If your clinic doesn't yet have a rehearsed emergency protocol in place, get in touch with NexGen Clinic to discuss training options.

This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.

Sources

• The Use of Hyaluronidase in Aesthetic Practice (ACE Group)
• Emergency management protocols and adjunctive aspirin use (PMC article)
• Management of a vascular occlusion associated with cosmetic injections (ACE Group)
• Practice standard for the management of dermal filler complications (Journal of Aesthetic Nursing)
• MHRA Yellow Card scheme

FAQ

What is the riskiest place for filler complications?

The glabella (between the eyebrows) and the nasal area carry the highest risk of vascular occlusion and ocular embolism due to limited collateral blood supply and proximity to the ophthalmic artery.

Why are people stopping filler treatments?

Growing awareness of complications like vascular occlusion, migration and lumpiness, alongside a wider aesthetic shift towards subtler, more natural-looking results, has made some patients more cautious about volume and more selective about practitioner experience.

How do you fix filler that has gone wrong?

Hyaluronidase can dissolve hyaluronic acid filler causing asymmetry, lumps or migration, following the ACE Group's dosing protocol, though infection must be ruled out or treated with antibiotics first.

How do I know if my filler has been botched?

Persistent asymmetry, hard lumps that don't soften over two to three weeks, discolouration, or pain beyond the expected bruising window are signs to seek a same-day clinical review rather than waiting it out.

When should hyaluronidase be given for a vascular occlusion?

As soon as vascular compromise is suspected, ideally within four hours and certainly within 48 hours, repeated hourly until skin colour and capillary refill improve.

Recommended

• Dermal filler safety: what to check before you book
• Filler aftercare: your first 48 hours and beyond
• Clinician Led Filler Migration: HA Often Dissolves Within 24–4